cytokines

Prediction of IL2 inducing peptides

Single-cell transcriptomic profiling of CAR T cells expressing synthetic receptors, termed "velocity CAR T" cells.

scRNA-seq analysis of cardiac immune cells in heart failure. 12 figures. Gja1/Cx43 cardio-immune interface.

Olink proteomics to identify differences in the cytokine profiles of patients with idiopathic pulmonary fibrosis, rheumatoid arthritis, and scleroderma

Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines

Theoretical analysis code for antigen encoding from cytokine dynamics.

Final project computational methods: Analysis of cytokines IFN-γ, IL-2, IL-4, IL-5, IL-6, IL-10 and TNFα levels in different groups. Status: finished

Code associated with 'Cytokine signature clusters as a tool to compare changes associated with tobacco product use in upper and lower airway samples' published in 2022 (PMID: 35318855).

science text

Synthekine — independent third-party profile of a public API surface, by API Evangelist. Synthekine is a clinical-stage biotechnology company discovering, developing, and commercializing the next generation of selective cytokine therapeutics. The company believes cytokine therapeutics engineered to be selective can fundamentally change the treatmen

Medikine — independent third-party profile of a public API surface, by API Evangelist. Medikine is a clinical-stage biopharmaceutical company based in San Diego, California, engineering a new class of medicines called PEPTIKINES — synthetic peptide mimetics of cytokines and growth-factor receptor agonists.